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P. Sˇta´dler, P. Matousˇ, P. Vita´sek and M. Sˇpacek
Objective. The feasibility of laparoscopic aortic surgery with robotic assis-
tance has been sufficiently demonstrated. Reported is the clinical experience
of robot-assisted aortoiliac reconstruction for occlusive disease and aneurysm
performed using the da Vinci system.
Methods. Between November 2005 and June 2006, 30 robot-assisted laparo-
scopic aortoiliac procedures were performed. Twenty-seven patients were
prospectively evaluated for occlusive disease, two patients for abdominal
aortic aneurysm, and one for common iliac artery aneurysm. Dissections of
the aorta and iliac arteries were performed laparoscopically using a transper-
itoneal direct approach technique, a modification of the Sˇta´dler method. The
robotic system was used to construct anastomoses, to perform thromboendar-
terectomies and, in most of the cases, for posterior peritoneal suturing.
Results. Robot-assisted procedures were successfully performed in all pa-
tients. The robot was used to perform both the abdominal aortic and common
iliac artery aneurysm anastomoses, the aortoiliac reconstruction with patch,
and to complete the central, end-to-side anastomosis in another operation.
Median operating time was 236 minutes (range, 180 to 360 minutes), with
a median clamp time of 54 minutes (range, 40 to 120 minutes). Operative
time is defined as the time elapsed from the initial incision to final skin clo-
sure. Median anastomosis time was 27 minutes (range, 20 to 60 minutes), and
median blood loss was 320 mL (range, 100 to 1500 mL). No conversion
was necessary, 30-day survival was 100%, median intensive care unit stay
was 1.8 days, and median hospital stay was 5.3 days. A regular oral diet
was resumed after a mean time of 2.5 days.
Conclusion. Robot-assisted laparoscopic surgery is a feasible technique for
aortoiliac surgery. The da Vinci robotic system facilitated the creation of the
aortic anastomosis and shortened aortic clamp time in comparison with
our laparoscopic techniques.
Endovascular aneurysm repair at 5 years: Does aneurysm diameter
predict outcome?
C.K. Zarins, T. Crabtree, D.A. Bloch, F.R. Arko, K. Ouriel and R.A. White
Objective. The appropriate size threshold for endovascular repair of small
abdominal aortic aneurysms (AAA) is unclear. We studied the outcome of en-
dovascular aneurysm repair (EVAR) as a function of preoperative aneurysm
diameter to determine the relationship between aneurysm size and long-term
outcome of endovascular repair.
Methods. We reviewed the results of 923 patients treated in a prospective,
multicenter clinical trial of EVAR. Small aneurysms were defined according
to two size thresholds of 5.5 cm and 5.0 cm. Two-way analysis was used to
compare patients with small aneurysms (<5.5 cm, n ¼ 441) with patients
with large aneurysms (5.5 cm, n ¼ 482). An ordered three-way analysis
was used to compare patients with small AAA (<5.0 cm, n ¼ 145), medium
AAA (5.0 to 5.9 cm, n ¼ 461), and large AAA (6.0 cm, n ¼ 317). The primary
outcome measures of rupture, AAA-related death, surgical conversion, sec-
ondary intervention, and survival were compared using Kaplan-Meier esti-
mates at 5 years.
Results. Median aneurysm size was 5.5 cm. The two-way comparison
showed that 5 years after EVAR, patients with small AAAs (<5.5 cm) had
a lower AAA-related death rate (1% vs 6%, P ¼ .006), a higher survival rate
(69% vs 57%, P ¼ .0002), and a lower secondary intervention rate (25% vs
32%, P ¼ .03) than patients with large AAAs (5.5 cm). Three-way analysis
revealed that patients with small aneurysms (<5.0 cm) were younger (P <
.0001) and were more likely to have a family history of aneurysm (P < .05),
prior coronary intervention (P ¼ .003), and peripheral occlusive disease
(P ¼ .008) than patients with larger aneurysms. Patients with smaller AAAs
also had more favorable aortic neck anatomy (P < .004). Patients with large
AAAs were older (P < .0001), had higher operative risk (P ¼ .01), and were
more likely to have chronic obstructive pulmonary disease (P ¼ .005), obesityYEJVS2335_2316_proof 
1078e5884/000600 + 03 $35.00/0  2006 Published by Elsevier Ltd.(P ¼ .03), and congestive heart failure (P ¼ .004). At 5 years, patients with
small AAAs had better outcomes, with 100% freedom from rupture vs 97%
for medium AAAs and 93% for large AAAs (P ¼ .02), 99% freedom from
AAA-related death vs 97% for medium AAAs and 92% for large AAAs
(P ¼ .02) and 98% freedom from conversion vs 92% for medium AAAs and
89% for large AAAs (P ¼ .01). Survival was significantly improved in small
(69%) and medium AAAs (68%) compared with large AAAs (51%,
P < .0001). Multivariate Cox proportional hazards modeling revealed that an-
eurysm size was a significant independent predictor of rupture (P ¼ .04; haz-
ard ratio [HR], 2.195), AAA-related death (P ¼ .03; HR, 2.007), surgical
conversion (P ¼ .007; HR, 1.827), and survival (P ¼ .001; HR, 1.351). There
were no significant differences in secondary intervention, endoleak, or migra-
tion rates between small, medium, and large aneurysms.
Conclusions. Preoperative aneurysm size is an important determinant of long-
term outcome after EVAR. Patients with small aneurysms (<5.0 cm) are more
favorable candidates for EVAR and have the best long-term outcomes, with
99% freedom from AAA death at 5 years. Patients with large aneurysms
(6.0 cm) have a shorter life expectancy and a higher risk of rupture, surgical
conversion, and aneurysm-related death after EVAR compared with patients
with smaller aneurysms. Nonetheless, 92% of patients with large AAAs are
protected from AAA-related death at 5 years. Patients with AAAs of an inter-
mediate size (5 to 6 cm) represent most of the patients treated with EVAR
and have a 97% freedom from AAA-related death at 5 years.
Outcome of common iliac arteries after straight aortic tube-graft
placement during elective repair of infrarenal abdominal aortic
aneurysms
R. Hassen-Khodja, P. Feugier, J.-P. Favre, A. Nevelsteen and J. Ferreira
Purpose. To determine the relative rates of common iliac artery (CIA) expan-
sion after elective straight aortic tube-graft replacement of infrarenal abdom-
inal aortic aneurysms (AAA).
Methods. Five participating centers in this 2004 study entered patients they
had managed by an aortoaortic tube graft for elective AAA repair. The pro-
cedures took place between January 1995 and December 2003. Postoperative
computed tomography (CT) scans were obtained for all patients in 2004 to
assess changes in CIA diameter. Measurements on preoperative and postop-
erative CT scans were all made at the same level using the same technique.
Results. Entered in the study were 147 patients (138 men, 9 women) with
a mean age of 68 years. Mean follow-up from aortic surgery to verification
of CIA diameter on the postoperative CT scan was 4.8 years. Mean preoper-
ative CIA diameter was 13.6 mm vs 15.2 mm postoperatively. No patient
developed occlusive iliac artery disease during follow-up. Three patients
(2%) required repeat surgery during follow-up for a CIA aneurysm. The
147 patients were divided into three groups based on preoperative CIA diam-
eter shown in CT scan: group A (n ¼ 59, 40.1%), both CIAwere of normal di-
ameter; group B (n ¼ 53, 36.1%), ectasia (diameter between 12 and 18 mm) of
at least one CIA; group C (n ¼ 35, 23.8%), an aneurysm (diameter > 18 mm)
of at least one CIA. CIA diameter increased by a mean of 1 mm (9.4%) over
5.5 years in group A vs 1.7 mm (12.1%) over 4.3 years in group B and 2.3 mm
(12.7%) over 4.2 years in group C. The three patients who required repeat sur-
gery for a CIA aneurysm during follow-up were all in group C. Four vari-
ables were associated with aneurysmal change in CIA: initial CIA diameter,
celiac aorta diameter on the preoperative CT scan, a coexisting aneurysm
site, and the follow-up duration.
Conclusions. Tube-graft placement during AAA surgery is justified even for
moderate CIA dilatation (<18mm). CIA aneurysmswith a preoperative diam-
eter 25 mm enlarge more rapidly and warrant insertion of a bifurcated graft
during the same surgical session as AAA repair. The evolutive potential of
CIA between 18 mm and 25 mm in diameter justifies a bifurcated graft when
the celiac aorta diameter is>25mm or the patient’s life expectancy is8 years.6 October 2006  600/602
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601AbstractsProgression of atherosclerotic renovascular disease: A prospective
population-based study
J.D. Pearce, B.L. Craven, T.E. Craven, K.T. Piercy, J.M. Stafford, M.S.
Edwards and K.J. Hansen
Objective. Previous reports from select hypertensive patients suggest that
atherosclerotic renovascular disease (RVD) is rapidly progressive and associ-
ated with a decline in kidney size and kidney function. This prospective,
population-based study estimates the incidence of new RVD and progression
of established RVD among elderly, free-living participants in the Cardiovas-
cular Health Study (CHS).
Method. The CHS is a multicenter, longitudinal cohort study of cardiovascu-
lar risk factors, morbidity, and mortality among men and women aged >65
years old. From 1995 through 1996, 834 participants underwent renal duplex
sonography (RDS) to define the presence or absence of significant RVD. Be-
tween 2002 and 2005, a second RDS study was performed in 119 participants
(mean study interval, 8.0  0.8 years). Significant RVD was defined as hemo-
dynamically significant stenosis (renal artery peak systolic velocity [RA-PSV]
exceeding 1.8 m/s) or renal artery occlusion. Prevalent RVD was significant
RVD at the first RDS, and incident disease was defined as new significant
RVD at the second RDS. Significant change of RVD was defined as a change
in RA-PSV of greater than two times the standard deviation of expected
change over time, regardless of hemodynamic significance or progression
to renal artery occlusion.
Results. The second RDS study cohort included 119 CHS participants with
235 kidneys (35% men; mean age, 82.8  3.4). On follow-up, no prevalent
RVD (n ¼ 13 kidneys; 6.0%) progressed to occlusion. Twenty-nine kidneys
without RVD at the first RDS demonstrated significant change in PSV at
the second RDS; including nine kidneys with new significant RVD
(8 new stenoses; 1 new occlusion). Controlling for within-subject correla-
tion, the overall estimated change in RVD among all 235 kidneys was
14.0% (95% confidence interval [CI], 9.2% to 21.4%), with progression to
significant RVD in 4.0% (95% CI, 1.9% to 8.2%). Longitudinal increase in
diastolic blood pressure and decrease in renal length were significantly as-
sociated with progression to new (ie, incident) significant RVD but not
prevalent RVD.
Conclusions. This is the first prospective, population-based estimate of inci-
dent RVD and progression of prevalent RVD among free-living elderly Amer-
icans. In contrast to previous reports among select hypertensive patients,
CHS participants with a low rate of clinical hypertension demonstrated a
significant change of RVD in only 14.0% of kidneys on follow-up of 8 years
(annualized rate, 1.3% per year). Progression to significant RVD was ob-
served in only 4.0% (annualized rate, 0.5% per year), and no prevalent
RVD progressed to occlusion.
The effects of the type of anesthesia on outcomes of lower extremity
infrainguinal bypass
N. Singh, A.N. Sidawy, K. Dezee, R.F. Neville, J. Weiswasser, S. Arora,
G. Aidinian, C. Abularrage, E. Adams, S. Khuri and W.G. Henderson
Objective. Three main types of anesthesia are used for infrainguinal bypass:
general endotracheal anesthesia (GETA), spinal anesthesia (SA), and epidural
anesthesia (EA). We analyzed a large clinical database to determine whether
the type of anesthesia had any effect on clinical outcomes in lower extremity
bypass.
Methods. This study is an analysis of a prospectively collected database by
the National Surgical Quality Improvement Program (NSQIP) of the Vet-
erans Affairs Medical Centers. All patients from 1995 to 2003 in the NSQIP
database who underwent infrainguinal arterial bypass were identified via
Current Procedural Terminology codes. The 30-day morbidity and mortal-
ity outcomes for various types of anesthesia were compared by using
univariate analysis and multivariate logistic regression to control for
confounders.
Results. The NSQIP database identified 14,788 patients (GETA, 9757
patients; SA, 2848 patients; EA, 2183 patients) who underwent a lower
extremity infrainguinal arterial bypass during the study period. Almost
all patients (99%) were men, and the mean age was 65.8 years. The type
of anesthesia significantly affected graft failure at 30 days. Comparedwith SA, the odds of graft failure were higher for GETA (odds ratio,
1.43; 95% confidence interval [CI], 1.16e1.77; P ¼ .001). There was no sta-
tistically significant difference in 30-day graft failure between EA and SA.
Regarding cardiac events, defined as postoperative myocardial infarction
or cardiac arrest, patients with normal functional status (activities of daily
living independence) and no history of congestive heart failure or stroke
did worse with GETA than with SA (odds ratio, 1.8; 95% CI, 1.32e2.48;
P < .0001). There was no statistically significant difference between EA
and SA in the incidence of cardiac events. GETA, when compared with
SA and EA, was associated with more cases of postoperative pneumonia
(odds ratio: 2.2 [95% CI, 1.1e4.4; P ¼ .034]. There was no significant differ-
ence between EA and SA with regard to postoperative pneumonia. Com-
pared with SA, GETA was associated with an increased odds of
returning to the operating room (odds ratio, 1.40; 95% CI, 1.20e1.64; P
< .001), as was EA (odds ratio, 1.17; 95% CI, 1.05e1.31; P ¼ .005).
GETA was associated with a longer surgical length of stay on univariate
analysis, but not after controlling for confounders. There was no significant
difference in 30-day mortality among the three groups with univariate or
multivariate analyses.
Conclusions. Although GETA is the most common type of anesthesia used in
infrainguinal bypasses, our results suggest that it is not the best strategy,
because it is associated with significantly worse morbidity than regional
techniques.
Resource utilization in the treatment of critical limb ischemia: The
effect of tissue loss, comorbidities, and graft-related events
L.L. Nguyen, S.R. Lipsitz, D.F. Bandyk, A.W. Clowes, G.L. Moneta, M. Belkin
and M.S. Conte
Objective. Resource utilization (RU) in the care of patients with critical limb
ischemia (CLI) is not well quantified. We present a cohort study to quantify
in-hospital RU and analyze the role of tissue loss (TL), comorbidities, and
vascular graft-related events (GREs) in patients undergoing peripheral
bypass for CLI.
Methods. A retrospective analysis of 1404 patients enrolled in a multicenter
clinical trial (PREVENT III) of vein bypass grafting for CLI was performed
with analysis of RU during the 1-year follow-up period. Univariate and
multivariable linear regressions were performed to determine RU
predictors.
Results. Compared with patients with rest pain, patients presenting with
TL as the indication for bypass surgery had a longer index length of
stay (mean, 9.8 vs 6.2 days), more rehospitalizations (mean, 1.6 vs 1.2),
and a longer cumulative length of stay (mean, 27.7 vs 17.3 days; P <
.0001 for all comparisons). Rehospitalizations over the ensuing year were
for additional procedures (37.5%), wound infection (14.6%), graft failure
(10.7%), and other cardiovascular (10%) and noncardiovascular (26%) rea-
sons. Early GRE (stenosis 70%, thrombosis, revision, or major amputation
within 30 days) occurred in 162 (11.5%) patients, resulting in a longer in-
dex length of stay (mean, 11.8 vs 8.6 days; P ¼ .0002) and cumulative
length of stay (mean, 25.9 vs 24.6 days; P ¼ .0043), but no difference in
the number of rehospitalizations (mean, 1.6 vs 1.5 days; P ¼ .3272). During
the 1-year follow-up, 554 (39.5%) patients had GREs, and this resulted in
more rehospitalizations (mean, 2.1 vs 1.1; P < .0001) and a longer cumula-
tive length of stay (mean, 28.2 vs 21.9 days; P < .0001) compared with pa-
tients without GRE. Multivariable analysis demonstrated the highly
positive association of TL (hazard ratio [HR], 1.75) and early GRE (HR,
1.77) with the index length of stay, whereas comorbiditiesdnamely, dialy-
sis dependency (HR, 1.31), nonsmoking status (HR, 1.29), hypertension
(HR, 1.26), and increasing age (HR, 1.01)dalso had strong effects. The ef-
fect of TL and GRE on later RU (number of rehospitalizations and cumu-
lative length of stay) was present but less pronounced than patient
comorbidities (namely, dialysis).
Conclusions. The stage of disease at presentation (TL vs rest pain) and the
patency of the bypass graft (freedom from GRE) are critical determinants
of RU over the first year after limb-salvage surgery. These effects predomi-
nate early (index length of stay) and persist through 1 year. Patient-specific
factors, particularly dialysis-dependent renal failure, are also critical comor-
bidities affecting RU in these patients.
602 AbstractsIncidence and natural history of Raynaud phenomenon: A long-
term follow-up (14 years) of a random sample from the general
population
P.H. Carpentier, B. Satger, D. Poensin and H.R. Maricq
Background. Because the natural history of primary Raynaud phenomenon
(RP) is unclear, we undertook this long-term (14 years) follow-up of an
epidemiologic study on RP to investigate the incidence, remittance rate,
and transition rate toward systemic sclerosis and other scleroderma spectrum
disorders in a population-based sample of subjects.
Methods. In 1988 and 1989, 296 subjects obtained from a random sample
of the general population of the Alpine valley of Tarentaise (southeast
France) completed a cross-sectional study on RP. Of these, 78 met the
diagnostic criteria for RP (RPþ). From April 2002 to March 2003, we
were able to get follow-up information on 292 people (dropout rate,
1.4%). Eighteen subjects (6.1%) had died, and the remaining 274 were
successfully contacted. They were first evaluated by a standardized
phone interview regarding their cold sensitivity, digital color changes,
and RP. If any significant medical changes related to RP and/or suggest-
ing scleroderma were reported, these subjects were invited for a medical
evaluation.
Results. Mortality was similar in RPþ and RP subjects, and no death was
due to an RP-related condition. Seven cases of new RP were diagnosed in
the RP group, which corresponds to an annual incidence rate of 0.25%.
Among the 72 RPþ subjects and the 7 subjects with a new RP available for
follow-up, none developed clinical features of scleroderma. A disappearance
of RP attacks for 2 winters or more was reported by 24 RPþ subjects (33%).
Conclusions. These results show that, in the general population, RP is most
often a benign condition and may disappear in a substantial proportion of
subjects.Eur J Vasc Endovasc Surg Vol 32, November 2006State-of-the-art treatment of chronic leg ulcers: A randomized
controlled trial comparing vacuum-assisted closure (V.A.C.) with
modern wound dressings
J.D.D. Vuerstaek, T. Vainas, J. Wuite, P. Nelemans, M.H.A. Neumann and
J.C.J.M. Veraart
Background. Current treatment modalities for chronic leg ulcers are time con-
suming, expensive, and only moderately successful. Recent data suggest that
creating a subatmospheric pressure by vacuum-assisted closure (V.A.C., KCI
Concepts, San Antonio, Texas) therapy supports the wound healing process.
Methods. The efficacy of vacuum-assisted closure in the treatment of chronic
leg ulcers was prospectively studied in a randomized controlled trial in which
60 hospitalized patients with chronic leg ulcers were randomly assigned to
either treatment by V.A.C. or therapy with conventional wound care tech-
niques. The primary outcome measure was the time to complete healing
(days). Statistical analysis was performed on the intention-to-treat basis.
Results. Themedian time to complete healingwas 29 days (95% confidence in-
terval [CI], 25.5 to 32.5) in theV.A.C. group comparedwith 45days (95%CI, 36.2
to 53.8) in the control group (P¼.0001). Further,wound bedpreparationduring
V.A.C. therapy was also significantly shorter at 7 days (95% CI 5.7 to 8.3) than
during conventionalwound care at 17days (95%CI, 10 to 24,P¼.005). The costs
of conventional wound care were higher than those of V.A.C. Both groups
showed a significant increase in quality of life at the end of therapy and a signif-
icant decrease in pain scores at the end of follow-up.
Conclusions. V.A.C. therapy should be considered as the treatment of choice
for chronic leg ulcers owing to its significant advantages in the time to com-
plete healing and wound bed preparation time compared with conventional
wound care. Particularly during the preparation stage, V.A.C. therapy
appears to be superior to conventional wound care techniques.
